Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Sumant Singh Chugh |
Contact phone | 205-996-9641 |
Dua signed dt | Oct. 28, 2008, midnight |
PI name | Sumant Singh Chugh |
Niddk signed dt | Nov. 18, 2008, midnight |